We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 83.60
Bid: 83.40
Ask: 84.20
Change: 3.00 (3.72%)
Spread: 0.80 (0.959%)
Open: 82.60
High: 84.60
Low: 81.20
Prev. Close: 80.60
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Long Term Incentive Plan Award

1 Dec 2020 09:42

RNS Number : 0909H
Costain Group PLC
01 December 2020
 

 

Costain Group PLC

(the "Company")

 

LONG TERM INCENTIVE PLAN AWARD

As announced on 20 November 2020, Helen Willis joined the Board of Costain Group PLC as chief financial officer with effect from 30 November 2020.

 

The Company announces the following grant of a share award to Helen Willis which is in accordance with the Company's published executive remuneration policy.

 

On 30 November 2020, an award was made to Helen Willis over 258,705 ordinary shares under the Costain Group PLC 2014 Long Term Incentive Plan (the "LTIP") in the form of an option with a nil exercise price (the "Award"). No consideration was paid for the grant of the Award.

 

The vesting of the Award is subject to the satisfaction of performance conditions assessed over the three financial years ending 31 December 2022. The performance conditions are exactly the same as those applicable to the LTIP Awards made to the chief executive officer, Alex Vaughan, and other senior executives on 7 October and are based on EPS as regards two thirds of each award and cash conversion as regards one third of each award. The EPS targets and cash conversion targets are stated below.

 

As for Alex Vaughan, the Remuneration Committee has taken into account market conditions and reduced the quantum of Helen Willis' award from 100% of salary to 55% of salary. The Committee has also prorated the Award for the period of employment during the performance period.

 

Vesting

EPS(aggregate EPS over the three year performance period)

Cash conversion(average cash conversion over the performance period)

Below threshold: 0%

Below 22.6 pence

Below 80%

Threshold: 15%

22.6 pence

80%

Between threshold and maximum: 15% - 100% pro rata on a straight-line basis

Between 22.6 pence and 26.7 pence

Between 80% and 100%

Maximum: 100%

26.7 pence

100%

 

The extent to which the Award granted to Helen Willis vests will normally be determined following the end of the three financial year performance period ending 31 December 2022, but the Award will not normally be released (so that it can be exercised) until the end of a further two year period (with no further performance conditions required after vesting).

 

The Remuneration Committee may reduce the extent to which the Award vests if the Committee considers that any of the value at vesting represents a "windfall gain", taking into account such factors as the Committee determines.

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

 

Notification of Dealing Form

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

a)

Name

HELEN MARGARET WILLIS

2.

Reason for the notification

a)

Position /status

CHIEF FINANCIAL OFFICER/ PDMR

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

COSTAIN GROUP PLC

b)

LEI code

213800PKIJBZ2EDTKC88

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

ORDINARY SHARES OF 50 PENCE EACH

 

ISIN: GB00B64NSP76

b)

Nature of the transaction

GRANT OF 258,705 OPTIONS UNDER THE COMPANY'S 2014 LONG TERM INCENTIVE PLAN

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

258,705

 

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

N/A

e)

Date of the transaction

 

30 NOVEMBER 2020

f)

Place of the transaction

 

OUTSIDE A TRADING VENUE

 

 

1 DECEMBER 2020

 

Enquiries:

Costain Group PLC

Tel: 01628 842 444

Sharon Harris, Company Secretary

MHP CommunicationsTim Rowntree, Peter Hewer

Tel: 020 3128 8100

costain@mhpc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZMGZLMLGGZG
Date   Source Headline
25th Apr 202411:41 amRNSScrip Dividend Reference Price
9th Apr 20244:16 pmRNSDirector/PDMR Shareholding
9th Apr 20241:32 pmRNSDirector/PDMR Shareholding
9th Apr 20249:33 amRNSAnnual Report and Accounts and Notice of 2024 AGM
4th Apr 20249:55 amRNSAdditional Listing
15th Mar 20248:30 amRNSKey Partner for Landmark Carbon Capture Project
12th Mar 20247:01 amRNSDirectorate Change
12th Mar 20247:00 amRNS2023 Full Year Results
27th Feb 202412:06 pmRNSInvestor Presentation via Investor Meet Company
10th Jan 20247:00 amRNSAMP8 Water Framework Win with NWG & Trading Update
2nd Jan 202412:56 pmRNSBlock listing Interim Review
1st Nov 202312:15 pmRNSTotal Voting Rights
27th Oct 20231:00 pmRNSDirector/PDMR Shareholding
25th Oct 20231:00 pmRNSAdditional Listing
19th Oct 20231:00 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirectorate Change
28th Sep 202312:00 pmRNSScrip Dividend Reference Price
25th Sep 20237:00 amRNSCostain and Ofwat Water Seminar
8th Sep 20232:26 pmRNSBlock listing Interim Review
5th Sep 20237:00 amRNSDividend Declaration
23rd Aug 20237:00 amRNSResults for the six months ended 30 June 2023
16th Aug 202310:00 amRNSInterim Results Investor Q&A
26th Jul 20237:00 amRNSCostain Refinancing of Bank and Bonding Facilities
17th Jul 20237:00 amRNSCostain Announces Key Contract Extension
30th Jun 20237:00 amRNSNew Payment Plan with Pension Scheme Trustee
22nd Jun 202310:38 amRNSCostain Appointed Magnox Decommissioning Framework
8th Jun 20234:17 pmRNSUpdate Regarding A66 Project
11th May 20234:49 pmRNSResult of AGM
11th May 20237:00 amRNSAGM Statement
20th Apr 20239:40 amRNSExternal Appointment
6th Apr 20232:29 pmRNSGrant of Share Plan Awards
6th Apr 202311:51 amRNSHolding(s) in Company
4th Apr 202310:33 amRNSNotice of AGM and Annual Report and Accounts
30th Mar 202312:58 pmRNSLong Term Incentive Plan - Listing Application
14th Mar 20237:00 amRNSResults For The Year Ended 31 December 2022
30th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20231:09 pmRNSBlock Listing Six Monthly Return
21st Dec 202212:47 pmRNSDirector/PDMR Shareholding
29th Nov 20227:00 amRNSCostain Partners with Heathrow Airport
21st Nov 20227:00 amRNSExtension of Bank Debt and Bonding Facilities
1st Nov 20224:42 pmRNSDirector/PDMR Shareholding
30th Sep 20222:32 pmRNSA303 Delivery Assurance Partnership
27th Sep 20227:00 amRNSDirectorate Change
24th Aug 20227:00 amRNSStrong operational resilience and cash performance
20th Jul 20227:00 amRNSTrading in line with strong cash performance
1st Jul 20224:40 pmRNSSecond Price Monitoring Extn
1st Jul 20224:35 pmRNSPrice Monitoring Extension
1st Jul 20229:00 amRNSBlock listing Interim Review
16th Jun 20222:17 pmRNSTR-1: Notification of Major holdings
1st Jun 202211:10 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.